Literature DB >> 8117535

New advances in inclusion-body myositis.

V Askanas1, W K Engel.   

Abstract

The major new advances in seeking the pathogenic mechanisms of sporadic inclusion-body myositis and hereditary inclusion-body myopathy are discussed. Hypotheses are presented regarding the possible causes and significance of amyloid deposits in sporadic inclusion-body myositis and the roles of abnormally accumulated ubiquitin, beta-amyloid protein, beta-amyloid precursor protein, alpha 1-antichymotrypsin, hyperphosphorylated tau, and prion protein in the vacuolated muscle fibers in both sporadic inclusion-body myositis and hereditary inclusion-body myopathy. Because hereditary inclusion-body myopathy is virtually free of Congophilic amyloid deposits but, like sporadic inclusion-body myositis, contains large accumulations of beta-amyloid protein, it is possible that the lesions in hereditary inclusion-body myopathy may represent "early" changes. There are striking similarities between the pathology of inclusion-body myositis muscle and brains affected by Alzheimer's disease in regard to accumulation of ubiquitin, beta-amyloid protein and its precursor protein, alpha 1-antichymotrypsin, and hyperphosphorylated tau.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8117535     DOI: 10.1097/00002281-199305060-00007

Source DB:  PubMed          Journal:  Curr Opin Rheumatol        ISSN: 1040-8711            Impact factor:   5.006


  14 in total

1.  Activation of the Unfolded Protein Response in Sporadic Inclusion-Body Myositis but Not in Hereditary GNE Inclusion-Body Myopathy.

Authors:  Anna Nogalska; Carla D'Agostino; W King Engel; Mafalda Cacciottolo; Shinichi Asada; Kazutoshi Mori; Valerie Askanas
Journal:  J Neuropathol Exp Neurol       Date:  2015-06       Impact factor: 3.685

Review 2.  Recent advances in muscular dystrophies and myopathies.

Authors:  J R Anderson
Journal:  J Clin Pathol       Date:  1995-07       Impact factor: 3.411

3.  Tau protein immunoreactivity in muscle fibers with rimmed vacuoles differs from that in regenerating muscle fibers.

Authors:  N Murakami; K Ishiguro; Y Ihara; I Nonaka; H Sugita; K Imahori
Journal:  Acta Neuropathol       Date:  1995       Impact factor: 17.088

4.  Muscle fiber degeneration in distal myopathy with rimmed vacuole formation.

Authors:  N Murakami; Y Ihara; I Nonaka
Journal:  Acta Neuropathol       Date:  1995       Impact factor: 17.088

Review 5.  Alzheimer's disease and prion proteins: a meeting made in muscle.

Authors:  P Gambetti; G Perry
Journal:  Am J Pathol       Date:  1994-12       Impact factor: 4.307

6.  Light and electron microscopic immunolocalization of presenilin 1 in abnormal muscle fibers of patients with sporadic inclusion-body myositis and autosomal-recessive inclusion-body myopathy.

Authors:  V Askanas; W K Engel; C C Yang; R B Alvarez; V M Lee; T Wisniewski
Journal:  Am J Pathol       Date:  1998-04       Impact factor: 4.307

7.  Amyloid-beta deposition in skeletal muscle of transgenic mice: possible model of inclusion body myopathy.

Authors:  K Fukuchi; D Pham; M Hart; L Li; J R Lindsey
Journal:  Am J Pathol       Date:  1998-12       Impact factor: 4.307

Review 8.  Inclusion body myositis: a view from the Caenorhabditis elegans muscle.

Authors:  Daniela L Rebolledo; Alicia N Minniti; Paula M Grez; Ricardo Fadic; Rebecca Kohn; Nibaldo C Inestrosa
Journal:  Mol Neurobiol       Date:  2008-09-05       Impact factor: 5.590

Review 9.  Newest pathogenetic considerations in inclusion-body myositis: possible role of amyloid-beta, cholesterol, relation to aging and to Alzheimer's disease.

Authors:  Valerie Askanas; W King Engel
Journal:  Curr Rheumatol Rep       Date:  2002-10       Impact factor: 4.592

10.  How citation distortions create unfounded authority: analysis of a citation network.

Authors:  Steven A Greenberg
Journal:  BMJ       Date:  2009-07-20
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.